Literature DB >> 17173210

The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection.

John J Carothers1, Michael G Bruce, Thomas W Hennessy, Michael Bensler, Julie M Morris, Alisa L Reasonover, Debby A Hurlburt, Alan J Parkinson, John M Coleman, Brian J McMahon.   

Abstract

The relationship between prior fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection is unknown. Among 125 enrolled patients, 8.8% had H. pylori isolates that were resistant to levofloxacin. Levofloxacin resistance was associated with any prior fluoroquinolone use over the previous 10 years and with the total number of fluoroquinolone courses prescribed (P<.001).

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17173210     DOI： 10.1086/510074

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  25 in total

1.  Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.

Authors:  Li-Hui Wang; Hong Cheng; Fu-Lian Hu; Jiang Li
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

3.  Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease.

Authors:  Karen Miernyk; Julie Morris; Dana Bruden; Brian McMahon; Debby Hurlburt; Frank Sacco; Alan Parkinson; Thomas Hennessy; Michael Bruce
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

4.  Alaska sentinel surveillance study of Helicobacter pylori isolates from Alaska Native persons from 2000 to 2008.

Authors:  Adrienne H Tveit; Michael G Bruce; Dana L Bruden; Julie Morris; Alisa Reasonover; Debby A Hurlburt; Thomas W Hennessy; Brian McMahon
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

Review 5.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

6.  Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development.

Authors:  Tatsuo Yamamoto; Tomomi Takano; Wataru Higuchi; Akihito Nishiyama; Ikue Taneike; Kumi Yoshida; Hiroko Kanda; Yuichiro Imamura
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

Review 7.  Treatment of Helicobacter pylori infection: Past, present and future.

Authors:  Vasilios Papastergiou; Sotirios D Georgopoulos; Stylianos Karatapanis
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

8.  Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population.

Authors:  Dana L Bruden; Michael G Bruce; Karen M Miernyk; Julie Morris; Debby Hurlburt; Thomas W Hennessy; Helen Peters; Frank Sacco; Alan J Parkinson; Brian J McMahon
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

Review 9.  Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.

Authors:  Simona Di Caro; Lucia Fini; Yayha Daoud; Fabio Grizzi; Antonio Gasbarrini; Antonino De Lorenzo; Laura Di Renzo; Sara McCartney; Stuart Bloom
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 10.  Fluoroquinolone-based protocols for eradication of Helicobacter pylori.

Authors:  Antonio Rispo; Pietro Capone; Fabiana Castiglione; Luigi Pasquale; Matilde Rea; Nicola Caporaso
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.